Shukra Pharmaceuticals has entered into a Memorandum of Understanding (MoU) with Borns Medical Robotics Inc., USA, a globally recognized company in robotic surgical technologies. The MoU sets out the framework for collaboration between the parties to introduce, promote and commercialize next-generation Al-enabled soft-tissue surgical robotic systems across India and select South Asian markets, including Nepal, Bangladesh, Sri Lanka, Maldives and Bhutan, subject to applicable regulatory approvals. The entire work will be executed through Shukra Robotics, a subsidiary of Shukra Pharmaceuticals.
Under the proposed collaboration, the parties intend to focus on expanding access to advanced robot-assisted minimally invasive soft-tissue surgeries by leveraging high-precision and stability-driven robotic platforms; Integration of artificial intelligence and digital surgery workflows to enable standardized procedure pathways and enhanced clinical efficiency; and Strengthening regional healthcare infrastructure through technology transfer, clinician training, and scalable deployment models. Borns Medical Robotics Inc. will contribute its expertise in surgical robotics platforms and Al-enabled technologies, while the company will leverage its established presence, regulatory execution capabilities, and healthcare market reach in India and South Asla.
Shukra Pharmaceuticals is an ambitious organisation with a deep-rooted focus on sustainability with its impressive range of solutions.
